{"product_id":"global-next-generation-sequencing-ngs-services-market-growth-status-and-outlook-2023-2029","title":"Global Next-Generation Sequencing (NGS) Services Market Growth (Status and Outlook) 2023-2029","description":"\u003cp\u003eGlobal Next-Generation Sequencing (NGS) Services Market Growth (Status and Outlook) 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eNext Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.\u003cbr\u003e\nLPI (LP Information)' newest research report, the “Next-Generation Sequencing (NGS) Services Industry Forecast” looks at past sales and reviews total world Next-Generation Sequencing (NGS) Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Next-Generation Sequencing (NGS) Services sales for 2023 through 2029. With Next-Generation Sequencing (NGS) Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next-Generation Sequencing (NGS) Services industry.\u003cbr\u003e\nThis Insight Report provides a comprehensive analysis of the global Next-Generation Sequencing (NGS) Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Next-Generation Sequencing (NGS) Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Next-Generation Sequencing (NGS) Services market.\u003cbr\u003e\nThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next-Generation Sequencing (NGS) Services and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next-Generation Sequencing (NGS) Services.\u003cbr\u003e\nThe global Next-Generation Sequencing (NGS) Services market size is projected to grow from US$ 3609.9 million in 2022 to US$ 10190 million in 2029; it is expected to grow at a CAGR of 16.0% from 2023 to 2029.\u003cbr\u003e\nThe classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.\u003cbr\u003e\nNext-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic \u0026amp; Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%. \u003cbr\u003e\nNorth America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%. \u003cbr\u003e\nEurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.\u003cbr\u003e\nThis report presents a comprehensive overview, market shares, and growth opportunities of Next-Generation Sequencing (NGS) Services market by product type, application, key players and key regions and countries.\u003cbr\u003e\nMarket Segmentation:\u003cbr\u003e\nSegmentation by type\u003cbr\u003e\n Targeted Sequencing\u003cbr\u003e\n Whole Exome Sequencing\u003cbr\u003e\n Whole Genome Sequencing\u003cbr\u003e\nSegmentation by application\u003cbr\u003e\n Hospitals and Clinics\u003cbr\u003e\n Biopharma Companies\u003cbr\u003e\n Academic \u0026amp; Research Organizations\u003cbr\u003e\n Others\u003cbr\u003e\nThis report also splits the market by region:\u003cbr\u003e\n Americas\u003cbr\u003e\n United States\u003cbr\u003e\n Canada\u003cbr\u003e\n Mexico\u003cbr\u003e\n Brazil\u003cbr\u003e\n APAC\u003cbr\u003e\n China\u003cbr\u003e\n Japan\u003cbr\u003e\n Korea\u003cbr\u003e\n Southeast Asia\u003cbr\u003e\n India\u003cbr\u003e\n Australia\u003cbr\u003e\n Europe\u003cbr\u003e\n Germany\u003cbr\u003e\n France\u003cbr\u003e\n UK\u003cbr\u003e\n Italy\u003cbr\u003e\n Russia\u003cbr\u003e\n Middle East \u0026amp; Africa\u003cbr\u003e\n Egypt\u003cbr\u003e\n South Africa\u003cbr\u003e\n Israel\u003cbr\u003e\n Turkey\u003cbr\u003e\n GCC Countries\u003cbr\u003e\nThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\n Eurofins Scientific\u003cbr\u003e\n Natera\u003cbr\u003e\n BGI\u003cbr\u003e\n Illumina\u003cbr\u003e\n Roche\u003cbr\u003e\n LabCorp\u003cbr\u003e\n Berry Genomics\u003cbr\u003e\n Brooks Life Sciences\u003cbr\u003e\n Macrogen\u003cbr\u003e\n Personalis\u003cbr\u003e\n Novogene\u003cbr\u003e\n Genotypic Technology\u003cbr\u003e\n Dna Link\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 102 Pages \/ MCW16226172","offer_id":47640121770290,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true},{"title":"January, 2023 \/ 102 Pages \/ MCW16226173","offer_id":47640121803058,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-next-generation-sequencing-ngs-services-market-growth-status-and-outlook-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}